Search research articles
Contact Us
Filters
Showing results (151-160 of 350) with videos related to
Page
of 35
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
March 26, 2014
Chemoradiation of hepatic malignancies: prospective, phase 1 study of full-dose capecitabine with escalating doses of yttrium-90 radioembolization
Ryan Hickey, Mary F Mulcahy, Robert J Lewandowski, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
September 19, 2018
From the Past to the Present: Insurer Coverage Frameworks for Next-Generation Tumor Sequencing
Julia R Trosman, Christine B Weldon, William J Gradishar, et al.
The Oncologist
|
September 18, 2024
A phase II study of FOLFOX combined with nab-paclitaxel in the treatment of metastatic or advanced unresectable gastric, gastroesophageal junction adenocarcinoma: a Big Ten Cancer Research Consortium trial
Marie S Dreyer, Mary Mulcahy, Masha Kocherginsky, et al.
Cancer
|
November 30, 2006
Extended safety and efficacy data on S-1 plus cisplatin in patients with untreated, advanced gastric carcinoma in a multicenter phase II study
Heinz-Joseph Lenz, Fa-Chyi Lee, Daniel G Haller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 20, 2005
Randomized phase II trial of the clinical and biological effects of two dose levels of gefitinib in patients with recurrent colorectal adenocarcinoma
Mace L Rothenberg, Bonnie LaFleur, Donna E Levy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 22, 2010
Surgery and adjuvant chemotherapy use among veterans with colon cancer: insights from a California study
Denise M Hynes, Elizabeth Tarlov, Ramon Durazo-Arvizu, et al.
Annals of Surgical Oncology
|
April 19, 2011
Fluorouracil-based chemoradiation with either gemcitabine or fluorouracil chemotherapy after resection of pancreatic adenocarcinoma: 5-year analysis of the U.S. Intergroup/RTOG 9704 phase III trial
William F Regine, Kathryn A Winter, Ross Abrams, et al.
The Oncologist
|
June 23, 2019
Phase II Study of Preoperative Chemoradiotherapy with Oxaliplatin, Infusional 5-Fluorouracil, and Cetuximab Followed by Postoperative Docetaxel and Cetuximab in Patients with Adenocarcinoma of the Esophagus: A Trial of the ECOG-ACRIN Cancer Research Group (E2205)
Michael K Gibson, Paul Catalano, Lawrence R Kleinberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 13, 2016
BATON-CRC: A Phase II Randomized Trial Comparing Tivozanib Plus mFOLFOX6 with Bevacizumab Plus mFOLFOX6 in Stage IV Metastatic Colorectal Cancer
Al B Benson, Igor Kiss, John Bridgewater, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 5, 2011
Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: an Eastern Cooperative Oncology Group trial
Patrick J Loehrer, Yang Feng, Higinia Cardenes, et al.
Page
of 35
Search research articles
Search
Showing results (151-160 of 350) with videos related to
Sort By:
Page
of 35
International Journal of Radiation Oncology, Biology, Physics
|
March 26, 2014
Chemoradiation of hepatic malignancies: prospective, phase 1 study of full-dose capecitabine with escalating doses of yttrium-90 radioembolization
Ryan Hickey, Mary F Mulcahy, Robert J Lewandowski, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
September 19, 2018
From the Past to the Present: Insurer Coverage Frameworks for Next-Generation Tumor Sequencing
Julia R Trosman, Christine B Weldon, William J Gradishar, et al.
The Oncologist
|
September 18, 2024
A phase II study of FOLFOX combined with nab-paclitaxel in the treatment of metastatic or advanced unresectable gastric, gastroesophageal junction adenocarcinoma: a Big Ten Cancer Research Consortium trial
Marie S Dreyer, Mary Mulcahy, Masha Kocherginsky, et al.
Cancer
|
November 30, 2006
Extended safety and efficacy data on S-1 plus cisplatin in patients with untreated, advanced gastric carcinoma in a multicenter phase II study
Heinz-Joseph Lenz, Fa-Chyi Lee, Daniel G Haller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 20, 2005
Randomized phase II trial of the clinical and biological effects of two dose levels of gefitinib in patients with recurrent colorectal adenocarcinoma
Mace L Rothenberg, Bonnie LaFleur, Donna E Levy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 22, 2010
Surgery and adjuvant chemotherapy use among veterans with colon cancer: insights from a California study
Denise M Hynes, Elizabeth Tarlov, Ramon Durazo-Arvizu, et al.
Annals of Surgical Oncology
|
April 19, 2011
Fluorouracil-based chemoradiation with either gemcitabine or fluorouracil chemotherapy after resection of pancreatic adenocarcinoma: 5-year analysis of the U.S. Intergroup/RTOG 9704 phase III trial
William F Regine, Kathryn A Winter, Ross Abrams, et al.
The Oncologist
|
June 23, 2019
Phase II Study of Preoperative Chemoradiotherapy with Oxaliplatin, Infusional 5-Fluorouracil, and Cetuximab Followed by Postoperative Docetaxel and Cetuximab in Patients with Adenocarcinoma of the Esophagus: A Trial of the ECOG-ACRIN Cancer Research Group (E2205)
Michael K Gibson, Paul Catalano, Lawrence R Kleinberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 13, 2016
BATON-CRC: A Phase II Randomized Trial Comparing Tivozanib Plus mFOLFOX6 with Bevacizumab Plus mFOLFOX6 in Stage IV Metastatic Colorectal Cancer
Al B Benson, Igor Kiss, John Bridgewater, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 5, 2011
Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: an Eastern Cooperative Oncology Group trial
Patrick J Loehrer, Yang Feng, Higinia Cardenes, et al.
Page
of 35